Application Nr Approved Date Route Status External Links
NDA212608 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ayvakit Is A Kinase Inhibitor Indicated For The Treatment Of Adults With Unresectable Or Metastatic Gastrointestinal Stromal Tumor (Gist) Harboring A Platelet-Derived Growth Factor Receptor Alpha (Pdgfra) Exon 18 Mutation, Including Pdgfra D842v Mutations. 1.1 Pdgfra Exon 18 Mutation-Positive Unresectable Or Metastatic Gastrointestinal Stromal Tumor (Gist) Ayvakit Is Indicated For The Treatment Of Adults With Unresectable Or Metastatic Gist Harboring A Platelet-Derived Growth Factor Receptor Alpha (Pdgfra) Exon 18 Mutation, Including Pdgfra D842v Mutations [See Dosage And Administration (2.1) ] .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Avapritinib

Comments